Abstract

Transdermals: The Skin as Part of a Drug Delivery System

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2011 - Volume 15, Number 4

Page(s): 308-315

Download in electronic PDF format for $75
  • Transdermals: The Skin as Part of a Drug Delivery System Page 1
  • Transdermals: The Skin as Part of a Drug Delivery System Page 2
  • Transdermals: The Skin as Part of a Drug Delivery System Page 3
  • Transdermals: The Skin as Part of a Drug Delivery System Page 4
  • Transdermals: The Skin as Part of a Drug Delivery System Page 5
  • Transdermals: The Skin as Part of a Drug Delivery System Page 6
  • Transdermals: The Skin as Part of a Drug Delivery System Page 7
  • Transdermals: The Skin as Part of a Drug Delivery System Page 8

Abstract

Transdermal delivery of drugs is effective and widely used to treat many different conditions. Transdermal drug delivery can be “individualized” for each patient by changing the drugs used, their concentrations, and the formulation. This type of drug delivery is routinely used for delivery of hormones, pain medications, nonsteroidal anti-inflammatory drugs, antinauseant medications, and many, many others. This article discusses the mechanism, the factors involved, the different penetration enhancers, how to control the rate of delivery, and provides some of the advantages and disadvantages of transdermal drug delivery.

Related Keywords

  • transdermal administration
  • topical preparations
  • drug delivery
  • percutaneous drug absorption
  • formulations
  • scopolamine hydrobromide
  • promethazine
  • hydrogels
  • excipients
  • skin layers
  • anxiolytic agents
  • antinausea
  • antiemetic
  • nausea and vomiting
  • motion sickness
  • dexamethasone
  • lorazepam
  • haloperidol
  • diphenhydramine hydrochloride
  • metoclopramide hydrochloride
  • buspirone hydrochloride
  • hormone replacement therapy
  • progesterone
  • estradiol
  • testosterone
  • ketoprofen
  • piroxicam
  • nonsteroidal anti-inflammatory drugs
  • NSAIDs
  • amitriptyline hydrochloride
  • baclofen
  • capsaicin
  • ketamine
  • neuropathy
  • neuropathic pain
  • pain relief
  • analgesia
  • analgesic
  • penetration enhancers
  • rate controllers

Related Categories

  • FORMULATIONS
  • HRT
  • MENTAL HEALTH
  • PAIN MANAGEMENT
  • DOSAGE FORMS/DRUG CARRIERS
  • NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2011
Pg. 308-315
Transdermals: The Skin as Part of a Drug Delivery System
Author(s): Allen Loyd V Jr
Mar/Apr 2003
Pg. 106-113
Veterinary Transdermal Medications: A to Z
Author(s): Davidson Gigi S
Mar/Apr 2018
Pg. 108-121
Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management
Author(s): Soni Abhishek, Gowthamarajan Kuppusamy, Radhakrishnan Arun
Jul/Aug 2023
Pg. 340-346
Formulation and In Vitro Evaluation of a Ramipril Entrapped in a Microsponge-based Drug-delivery System
Author(s): Taghi Hassanien Sagban, Abdulbaqi Mustafa R, Samein Laith Hamza, Rahmani Maha H Philip
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
Jan/Feb 2012
Pg. 62-63
The Use of Pluronic Lecithin Organogels in the Transdermal Delivery of Drugs
Author(s): Bramwell Bethany L, Williams LaVonn A
May/Jun 2014
Pg. 256-261
Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery
Author(s): Boddu Sai HS, Bonam Sindhu Prabha, Wei Yangjie, Alexander Kenneth
Mar/Apr 2004
Pg. 101-105
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs
Author(s): Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K
May/Jun 2016
Pg. 250-256
Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives
Author(s): Trimble John, Light Bob
Jan/Feb 2023
Pg. 30-37
Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays
Author(s): Allen Loyd V Jr
Nov/Dec 2014
Pg. 512-515
In Vitro Skin Penetration and Skin Content of Progesterone from Various Topical Formulations
Author(s): Heustess Allie, Asbill Scott, Eagerton David, Arnold John
Jan/Feb 2019
Pg. 65-69
Transdermal Delivery of Metformin Hydrochloride from a Semisolid Vehicle
Author(s): Polonini Hudson, Lopes Cândido Paulo José, Andrade Junquiera Laura, Loures Sharlene, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson
Nov/Dec 1999
Pg. 496-500
Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations
Author(s): Goodwin Donald A, Fuhram L Clifton
Nov/Dec 2018
Pg. 498-503
Gabapentin in Elastic Liposomes: Preparation, Characterization, Drug Release, and Penetration Through Porcine Skin
Author(s): Le Uyen Minh, Baltzley Sarah, AlGhananeem Abeer
Sep/Oct 2017
Pg. 356
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Author(s): Allen Loyd V Jr
Nov/Dec 2022
Pg. 490-495
Compounding with Microneedle Arrays, Part 2: Preparation and Administration Methods
Author(s): Allen Loyd V Jr
Sep/Oct 2023
Pg. 424-430
Evaluation of Compounded Transdermal Analgesic Formulations Using the Franz Finite Dose Model
Author(s): Baneshi Marzieh, Tyagi Deependra, Panneerselvam Ezilrani, MacKenzie Graham, Coleman Johngary, Zhang Shine X
Nov/Dec 2017
Pg. 530-535
Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives
Author(s): Trimble John O, Light Bob
Mar/Apr 2015
Pg. 152-160
Transdermal Delivery of Nisoldipine: Refinement of Vehicles
Author(s): El Maghraby Gamal M, Ahmed Amal A, Osman Mohamed A
Mar/Apr 2015
Pg. 161-166
Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations
Author(s): Bryson Evan, Hartman Rachel, Arnold John, Gorman Greg, Sweitzer Sarah.Asbill Scott